Cliff Asness's RMD Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 255,884 shares of ResMed Inc. (RMD) worth $61.63 M, representing 0.03% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 53 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in RMD, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2018, adding 535,803 shares. Largest reduction occurred in Q1 2019, reducing 309,809 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's ResMed (RMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly ResMed (RMD) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +33,773 | Add 15.21% | 255,884 | $240.87 |
| Q3 2025 | +35,565 | Add 19.07% | 222,111 | $273.59 |
| Q2 2025 | -215,870 | Reduce 53.64% | 186,546 | $256.28 |
| Q1 2025 | -222,638 | Reduce 35.62% | 402,416 | $219.15 |
| Q4 2024 | +357,466 | Add 133.59% | 625,054 | $228.69 |
| Q3 2024 | +94,805 | Add 54.87% | 267,588 | $244.12 |
| Q2 2024 | +29,538 | Add 20.62% | 172,783 | $191.42 |
| Q1 2024 | +46,448 | Add 47.98% | 143,245 | $197.75 |
| Q4 2023 | -10,105 | Reduce 9.45% | 96,797 | $172.02 |
| Q3 2023 | +20,165 | Add 23.25% | 106,902 | $147.87 |
| Q2 2023 | +14,285 | Add 19.72% | 86,737 | $218.50 |
| Q1 2023 | -12,917 | Reduce 15.13% | 72,452 | $217.29 |
| Q4 2022 | +7,069 | Add 9.03% | 85,369 | $206.00 |
| Q3 2022 | -17,829 | Reduce 18.55% | 78,300 | $218.30 |
| Q2 2022 | -74,266 | Reduce 43.58% | 96,129 | $209.63 |
| Q1 2022 | -85,459 | Reduce 33.40% | 170,395 | $242.51 |
| Q4 2021 | +12,402 | Add 5.09% | 255,854 | $260.48 |
| Q3 2021 | -64,509 | Reduce 20.95% | 243,452 | $263.55 |
| Q2 2021 | -51,168 | Reduce 14.25% | 307,961 | $245.77 |
| Q1 2021 | +18,840 | Add 5.54% | 359,129 | $193.53 |
| Q4 2020 | -2,889 | Reduce 0.84% | 340,289 | $209.15 |
| Q3 2020 | +110,908 | Add 47.75% | 343,178 | $171.43 |
| Q2 2020 | -32,580 | Reduce 12.30% | 232,270 | $189.54 |
| Q1 2020 | -24,003 | Reduce 8.31% | 264,850 | $147.29 |
| Q4 2019 | -113,881 | Reduce 28.28% | 288,853 | $154.29 |
| Q3 2019 | -69,068 | Reduce 14.64% | 402,734 | $135.11 |
| Q2 2019 | -182,071 | Reduce 27.85% | 471,802 | $120.83 |
| Q1 2019 | -309,809 | Reduce 32.15% | 653,873 | $103.43 |
| Q4 2018 | +74,232 | Add 8.35% | 963,682 | $113.87 |
| Q3 2018 | +535,803 | Add 151.51% | 889,450 | $115.34 |
| Q2 2018 | +17,225 | Add 5.12% | 353,647 | $103.58 |
| Q1 2018 | -28,207 | Reduce 7.74% | 336,422 | $98.47 |
| Q4 2017 | +66,416 | Add 22.27% | 364,629 | $84.69 |
| Q3 2017 | -39,825 | Reduce 11.78% | 298,213 | $76.96 |
| Q2 2017 | -54,465 | Reduce 13.88% | 338,038 | $77.87 |
| Q1 2017 | -23,546 | Reduce 5.66% | 392,503 | $71.97 |
| Q4 2016 | -86,087 | Reduce 17.14% | 416,049 | $62.05 |
| Q3 2016 | -60,136 | Reduce 10.70% | 502,136 | $64.79 |
| Q2 2016 | +163,666 | Add 41.06% | 562,272 | $63.23 |
| Q1 2016 | +25,460 | Add 6.82% | 398,606 | $57.82 |
| Q4 2015 | +186,287 | Add 99.69% | 373,146 | $53.69 |
| Q3 2015 | +63,613 | Add 51.61% | 186,859 | $50.96 |
| Q2 2015 | -58,192 | Reduce 32.07% | 123,246 | $56.37 |
| Q1 2015 | -24,445 | Reduce 11.87% | 181,438 | $71.78 |
| Q4 2014 | -19,005 | Reduce 8.45% | 205,883 | $56.06 |
| Q3 2014 | -172,700 | Reduce 43.44% | 224,888 | $49.27 |
| Q2 2014 | -10,300 | Reduce 2.53% | 397,588 | $50.63 |
| Q1 2014 | -5,700 | Reduce 1.38% | 407,888 | $44.69 |
| Q4 2013 | +40,159 | Add 10.75% | 413,588 | $47.08 |
| Q3 2013 | +5,929 | Add 1.61% | 373,429 | $52.82 |
| Q2 2013 | +367,500 | Add 0.00% | 367,500 | $45.13 |
| Q4 2012 | +331,100 | Add 0.00% | 331,100 | $41.57 |
Cliff Asness's ResMed Investment FAQs
Cliff Asness first purchased ResMed Inc. (RMD) in Q4 2012, acquiring 331,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held ResMed Inc. (RMD) for 53 quarters since Q4 2012.
Cliff Asness's largest addition to ResMed Inc. (RMD) was in Q3 2018, adding 889,450 shares worth $102.59 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 255,884 shares of ResMed Inc. (RMD), valued at approximately $61.63 M.
As of the Q4 2025 filing, ResMed Inc. (RMD) represents approximately 0.03% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in ResMed Inc. (RMD) was 963,682 shares, as reported at the end of Q4 2018.